JP2013516490A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013516490A5 JP2013516490A5 JP2012548200A JP2012548200A JP2013516490A5 JP 2013516490 A5 JP2013516490 A5 JP 2013516490A5 JP 2012548200 A JP2012548200 A JP 2012548200A JP 2012548200 A JP2012548200 A JP 2012548200A JP 2013516490 A5 JP2013516490 A5 JP 2013516490A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkylene
- pharmaceutically acceptable
- acceptable salt
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29394910P | 2010-01-11 | 2010-01-11 | |
| US61/293,949 | 2010-01-11 | ||
| PCT/US2011/020639 WO2011085291A1 (en) | 2010-01-11 | 2011-01-10 | 1 - (2 - phenoxymethylphenyl) piperazine compounds as serotonin and norepinephrine reuptake inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013516490A JP2013516490A (ja) | 2013-05-13 |
| JP2013516490A5 true JP2013516490A5 (enExample) | 2013-12-19 |
| JP5705239B2 JP5705239B2 (ja) | 2015-04-22 |
Family
ID=43608270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012548200A Expired - Fee Related JP5705239B2 (ja) | 2010-01-11 | 2011-01-10 | セロトニンおよびノルエピネフリン再取込みインヒビターとしての１−（２−フェノキシメチルフェニル）ピペラジン化合物 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US8778949B2 (enExample) |
| EP (1) | EP2523945A1 (enExample) |
| JP (1) | JP5705239B2 (enExample) |
| WO (1) | WO2011085291A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2358676T1 (sl) | 2008-11-14 | 2013-01-31 | Theravance, Inc. | Kristalinična oblika 4-(2-(2-fluorofenoksimetil)fenil)piperidinske spojine |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| DE2549999A1 (de) | 1975-11-07 | 1977-05-12 | Boehringer Mannheim Gmbh | Piperidin-derivate und verfahren zu ihrer herstellung |
| IL56369A (en) | 1978-01-20 | 1984-05-31 | Erba Farmitalia | Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them |
| US4198417A (en) | 1979-01-10 | 1980-04-15 | American Hoechst Corporation | Phenoxyphenylpiperidines |
| EP0190496A3 (en) | 1984-12-13 | 1987-05-27 | Beecham Group Plc | Piperidine derivatives having a gastro-intestinal activity |
| US4956388A (en) | 1986-12-22 | 1990-09-11 | Eli Lilly And Company | 3-aryloxy-3-substituted propanamines |
| DE3835291A1 (de) | 1988-04-19 | 1989-11-02 | Bayer Ag | 1,3-disubstituierte pyrrolidine |
| GB9324018D0 (en) | 1993-11-23 | 1994-01-12 | Merck Sharp & Dohme | Therapeutic agents |
| US6518284B2 (en) | 1998-11-18 | 2003-02-11 | Faes, Fabrica Espanola De Productos Quimicos Y Farmaceuticos S.A. | 4-substituted piperidines |
| JP2000204040A (ja) * | 1999-01-14 | 2000-07-25 | Sankyo Co Ltd | 精神神経症状の治療剤又は予防剤 |
| US6630504B2 (en) | 2000-08-31 | 2003-10-07 | Pfizer Inc. | Phenoxyphenylheterocyclyl derivatives as SSRIs |
| US7294637B2 (en) | 2000-09-11 | 2007-11-13 | Sepracor, Inc. | Method of treating addiction or dependence using a ligand for a monamine receptor or transporter |
| UA81749C2 (uk) | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
| US7384941B2 (en) | 2002-08-23 | 2008-06-10 | Eli Lilly And Company | 2-(phenoxymethyl)-and 2-(phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors |
| BRPI0408320A (pt) | 2003-04-04 | 2006-03-07 | Lundbeck & Co As H | composto, composição farmacêutica, uso de um composto, e, método para o tratamento de um distúrbio afetivo |
| BRPI0411594A (pt) | 2003-06-17 | 2006-08-29 | Pfizer | derivados de n-pirrolidin-3-il-amida como inibidores de re-absorção de serotonina e noradrenalina |
| CA2553289A1 (en) | 2004-01-13 | 2005-07-28 | Pfizer Inc. | Piperazine derivatives which exhibit activity as serotonin and noradrenaline re-uptake inhibitors |
| SE0400234D0 (sv) * | 2004-02-06 | 2004-02-06 | Active Biotech Ab | New compounds, methods for their preparation and use thereof |
| WO2005092835A1 (en) | 2004-03-05 | 2005-10-06 | Eli Lilly And Company | Pharmaceutical compounds |
| AP2006003771A0 (en) | 2004-04-30 | 2006-10-31 | Warner Lambert Co | Substituted morpholine compounds for the treatmentof central nervous system disorders |
| US20070142389A1 (en) | 2005-12-20 | 2007-06-21 | Pfizer Inc. | Piperidine derivatives |
| CN101506164A (zh) | 2006-08-23 | 2009-08-12 | 辉瑞产品公司 | 哌啶衍生物 |
| US8026257B2 (en) | 2007-07-11 | 2011-09-27 | Bristol-Myers Squibb Company | Substituted heterocyclic ethers and their use in CNS disorders |
| WO2009081259A1 (en) | 2007-12-21 | 2009-07-02 | Pfizer Inc. | Phenoxy-pyridyl derivatives |
| BRPI0914891A2 (pt) | 2008-06-20 | 2015-11-24 | Metabolex Inc | agonistas de aril gpr119 e usos dos mesmos |
| SI2358676T1 (sl) | 2008-11-14 | 2013-01-31 | Theravance, Inc. | Kristalinična oblika 4-(2-(2-fluorofenoksimetil)fenil)piperidinske spojine |
| EP2550252B1 (en) | 2010-03-22 | 2015-05-06 | Theravance Biopharma R&D IP, LLC | 1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds |
-
2011
- 2011-01-10 EP EP20110700711 patent/EP2523945A1/en not_active Withdrawn
- 2011-01-10 WO PCT/US2011/020639 patent/WO2011085291A1/en not_active Ceased
- 2011-01-10 JP JP2012548200A patent/JP5705239B2/ja not_active Expired - Fee Related
- 2011-01-10 US US12/987,359 patent/US8778949B2/en not_active Expired - Fee Related
-
2014
- 2014-06-05 US US14/296,685 patent/US9012460B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011529069A5 (enExample) | ||
| US8716349B2 (en) | Compositions and methods for the treatment of somatosensory disorders | |
| JP6595078B2 (ja) | アミノカルボニルカルバメート化合物 | |
| JP2009531277A5 (enExample) | ||
| EA022459B1 (ru) | Производные транилципромина в качестве ингибиторов гистон деметилаз lsd1 и/или lsd2 | |
| EA016687B8 (ru) | Производные циклопропиламида | |
| HRP20120920T1 (hr) | Spojevi 4-[2-(2 fluorofenoksimetil)fenil]piperidina | |
| NZ589497A (en) | Process for the synthesis of arformoterol | |
| JP2011505356A5 (enExample) | ||
| JP2025505745A5 (enExample) | ||
| WO2010011811A4 (en) | 3-(phenoxyphenylmethyl)pyrrolidine compounds | |
| JP2016529228A5 (enExample) | ||
| US20230218562A1 (en) | Aminocarbonylcarbamate compounds | |
| JP2013522363A5 (enExample) | ||
| JP2010508245A5 (enExample) | ||
| PE20070247A1 (es) | Derivados dimetilamino como agentes inhibidores de la recaptacion doble de serotonina y norepinefrina con alta selectividad | |
| RU2013105479A (ru) | Кристаллическая форма соединения 3-феноксиметилпирролидина | |
| JP2013532170A5 (enExample) | ||
| JP2011512334A5 (enExample) | ||
| JP5705239B2 (ja) | セロトニンおよびノルエピネフリン再取込みインヒビターとしての１−（２−フェノキシメチルフェニル）ピペラジン化合物 | |
| RU2019123563A (ru) | Новые комбинации антагонистов н3-рецепторов и ингибиторов обратного захвата норадреналина и их терапевтическое применение | |
| RU2790360C2 (ru) | Аминокарбонилкарбаматные соединения | |
| HK40007355B (en) | Aminocarbonylcarbamate compounds | |
| JP2008506645A5 (enExample) | ||
| HK1233615A1 (en) | Aminocarbonylcarbamate compounds |